SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-16-012607
Filing Date
2016-03-11
Accepted
2016-03-10 19:44:21
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A DEC 2015 arbutusform10-kamarch2016.htm 10-K/A 252549
2 EXHIBIT 31.1 10K/A CEO exhibit31110-kacertceo.htm EX-31.1 14602
3 EXHIBIT 31.2 10-K/A CFO exhibit31210-kacertcfo.htm EX-31.2 14700
4 EXHIBIT 32.1 SOX 10-K/A CEO exhibit321sox10-kaceo.htm EX-32.1 7346
5 EXHIBIT 32.2 SOX 10-K/A CFO exhibit322sox10-kacfo.htm EX-32.2 7834
  Complete submission text file 0001628280-16-012607.txt   298200
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34949 | Film No.: 161499092
SIC: 2834 Pharmaceutical Preparations